Cookies show us what works. Privacy
Cookies show us what works. Privacy
Johnson & Johnson (JNJ) has not announced its next earnings date. The next report covers the quarter ending Dec 31, 2026. A year earlier it reported the same quarter on Jan 21, 2026. Analysts expect earnings per share of $2.92 (17 analysts) on revenue of $26.4B.
Last report, Oct 13, 2026: EPS $2.59 against $2.53 expected (+2.4%). The stock moved +2.1% the next day. Beat the EPS estimate in 7 of the last 8 reports. The stock moved 0.8% on average the next day, up or down; the largest move was +2.1%.
| Reported | Quarter ended | EPS | Estimate | Surprise | Next day |
|---|---|---|---|---|---|
| Oct 13, 2026 | Sep 27, 2026 | $2.59 | $2.53 | +2.4% | +2.1% |
| Jul 15, 2026 | Jun 28, 2026 | $2.90 | $2.84 | +2.1% | +1.2% |
| Apr 14, 2026 | Mar 29, 2026 | $2.70 | $2.68 | +0.7% | -0.6% |
| Jan 21, 2026 | Dec 31, 2025 | $2.46 | $2.46 | 0.0% | +0.2% |
| Oct 14, 2025 | Sep 28, 2025 | $2.80 | $2.76 | +1.4% | +0.2% |
| Jul 16, 2025 | Jun 29, 2025 | $2.77 | $2.68 | +3.4% | -1.1% |
| Apr 15, 2025 | Mar 30, 2025 | $2.77 | $2.58 | +7.4% | +0.2% |
| Jan 22, 2025 | Dec 31, 2024 | $2.04 | $2.01 | +1.5% | +0.9% |
Johnson & Johnson (JNJ) has not announced its next earnings date. The next report covers the quarter ending Dec 31, 2026. A year earlier it reported the same quarter on Jan 21, 2026.
$2.92 a share, the average of 17 analysts, for the quarter ending Dec 31, 2026. The revenue estimate is $26.4B.
Yes. Last report, Oct 13, 2026: EPS $2.59 against $2.53 expected (+2.4%). The stock moved +2.1% the next day.
Report dates come from the Alpha Vantage earnings calendar and stay expected until the company confirms them. EPS is as reported against the analyst average; the next-day move is close to close. Not investment advice.